Research intelligence
Synthesis, coding, journey mapping, segmentation, and behavioural modelling across complex patient and professional pathways.
See related case oneExplore
Frontera Global
AI-driven researchfor pharma teams.
Behavioural intelligence for organisations that need to understand decisions, design change, and deliver real-world impact across patients, professionals, and systems.
Global and regional pharma teams
AI-enabled behavioural modelling
Research, strategy, creative activation
Experience with teams across
'%20fill='%23fff'%3e%3cpath%20d='m9.66%203.86h10.75l6.59%2022.33h0.1l4.52-22.33h8.12l-6.83%2032.2h-10.7l-6.74-22.28h-0.09l-4.47%2022.28h-8.12z'/%3e%3cpath%20d='m42.91%203.86h8.63l-2.54%2012.32h10.2l2.54-12.32h8.63l-6.69%2032.2h-8.68l2.86-13.79h-10.15l-2.86%2013.79h-8.62z'/%3e%3cpath%20d='m93.06%2011.15a16.18%2016.18%200%200%200-7.06-1.48c-3.41%200-6.18%200.51-6.18%203.09%200%204.57%2012.5%202.86%2012.5%2012.64%200%208.9-8.26%2011.21-15.73%2011.21a36%2036%200%200%201-10-1.66l2-6.55c1.71%201.11%205.12%201.85%207.93%201.85s6.87-0.51%206.87-3.83c0-5.17-12.5-3.23-12.5-12.32%200-8.3%207.29-10.8%2014.35-10.8%204%200%207.7%200.42%209.87%201.43z'/%3e%3c/g%3e%3c/svg%3e)
Stallergenes Greer
Stallergenes GreerAbout
Built for teams who need behaviour to change, not just messages to land.
Frontera helps pharma teams move from evidence to adoption by modelling how patients, professionals, and systems actually make decisions.
Our Connected Behavioural Intelligence System uses AI-enabled synthesis and behavioural science to decode decision drivers, identify friction, and design interventions that can be deployed across markets.
45+
source types synthesised across launch and market planning work
3
connected disciplines: research intelligence, strategy, creative activation
1
system for turning behavioural evidence into action
Offer
One integrated team across intelligence, strategy, and activation.
Frontera is structured for the messy middle of healthcare: where data is fragmented, behaviours are hard to shift, and strategy only matters if it changes what happens next.
Strategy design
Launch planning, intervention design, market alignment, omnichannel planning, and practical frameworks teams can adopt.
See related case threeExploreCreative activation
Experience systems, campaigns, content, and scalable activation programmes shaped around what people need to think, feel, and do.
See related case sevenExploreCBI system
A simple system for complex behaviour.
Connected Behavioural Intelligence turns research into a working model of change: what is happening, why it is happening, and what can shift it.
01
Decode decisions
Unify global and local evidence, then use AI-assisted behavioural analysis to reveal decision drivers, barriers, and pathway friction.
02
Design change
Translate behavioural evidence into strategy, interventions, messaging, experience architecture, and measurable engagement models.
03
Deliver outcomes
Package the work into practical tools, playbooks, campaigns, and optimisation loops that teams can use in the real world.
Proof
Behavioural work, built for real-world adoption.
Selected work across launch strategy, patient experience, omnichannel planning, medical affairs, and scalable activation.
Research + IntelligenceEUR Region
Case ONE
Uncovering how decisions are made across complex, multi-market pathways
AI-driven analysis and behavioural science helped map how patients, professionals, and systems behave across diverse reimbursement environments.
Deliverable
Care pathway maps, friction heatmaps, audience archetypes, and strategic risk frameworks to guide market planning and intervention design.
Outcome
Provided a clear behavioural foundation for launch, enabling markets to plan with confidence, prioritise interventions, and unlock real-world adoption.
Read the behavioural approach
Objective
Map how dual-indication pathways operate across markets, identifying behavioural, structural, and reimbursement barriers shaping access and adoption.
Role of AI
Enabled large-scale, multi-language analysis — accelerating transcription, data processing, and consistent identification of patterns across markets and pathways, enabling accurate behavioural coding to reveal archetypes.
Impact
Revealed systemic barriers beyond clinical factors — including reimbursement gating, referral ambiguity, and capacity constraints — limiting progression and scale.
Journey MappingGlobal
Case THREE
Designing patient support through real-world behaviour and experience
Journey mapping and behavioural modelling defined the support patients need to adopt and sustain home treatment with confidence.
Deliverable
End-to-end patient experience map, PSP touchpoint architecture, and engagement blueprint to guide, design, and brief the global patient support programme.
Outcome
Delivered a behaviourally-led blueprint for patient support, ensuring the programme is built around how patients actually experience, adopt, and sustain treatment in real life.
Read the behavioural approach
Objective
Enable the successful global launch of home self-injection for a rare disease treatment by understanding how patients and professionals behave across the treatment journey.
Role of AI
Structured analysis of complex behavioural data to identify patterns across patient types, treatment stages, and markets — enabling faster, more consistent modelling of journeys and intervention points.
Impact
Defined the critical moments and support needs required to transition patients from clinical to home administration — including training, confidence-building, and adherence support across cycles.
Enabled alignment on how support should evolve from onboarding through to long-term independence.
Experience Design + Automated ActivationEUR Region
Case SEVEN
Using targeted profiling and personalised outreach to drive clinic growth
A behaviour-led activation model used peer proof, intelligent profiling, and personalised outreach to engage high-potential clinics at scale.
Deliverable
Automated activation programme including target profiling, market-specific prospect lists, personalised outreach templates, peer-led content journeys, tailored landing pages, influencer case examples and response workflows.
Outcome
Delivered a scalable personalised activation model designed to double the audience working with the client by replacing generic product push with persuasive peer-led proof, targeted data and automated outreach.
Read the behavioural approach
Objective
Create a scalable activation approach to identify and engage high-potential aesthetics clinics across Europe, encouraging them to preferentially select the client's products by demonstrating the value achieved by influential peer clinics.
Role of AI
AI supported high-potential target identification, lookalike audience generation and personalisation at scale. Clay enabled personalised data collection and integration, while n8n workflows supported repeated outreach, response capture and adaptive follow-up.
Impact
Shifted activation from broad product promotion to targeted persuasion by example, helping clinics understand the value of partnership through peer success.
Created a "peloton strategy" across markets, where a small group of credible aesthetics professionals led growth by showing what was possible and encouraging others to follow.
Case TWO
Launch Strategy Optimisation / Validation
Translating behavioural insight into how global strategy lands in markets.
Launch strategy validation
Read the behavioural approach
Objective
Understand how global asthma strategy will be experienced in real-world settings, identifying where patient behaviour may accelerate or delay adoption.
Role of AI
Accelerated pattern recognition across large, complex datasets, enabling structured behavioural analysis, rapid synthesis, and consistent identification of key intervention points.
Impact
Revealed critical gaps between strategy assumptions and patient reality, including normalisation of symptoms and delayed escalation, shaping where strategy would succeed or stall.
Aligned global and regional teams on priority actions, enabling focused investment to support adoption and unlock early growth.
Case FOUR
Omnichannel Engagement Design
Harnessing behavioural insight into coordinated, real-world engagement across channels, journeys, and markets.
Behaviour-led omnichannel planning
Read the behavioural approach
Objective
Define and enable a future-fit omnichannel approach that translates global strategy into practical, market-ready engagement, grounded in real-world customer behaviour and decision-making.
Role of AI
Analysis of large datasets and benchmarking inputs to identify patterns in behaviour, channel effectiveness, and engagement models — accelerating insight generation and enabling scalable planning frameworks.
Impact
Shifted omnichannel from channel-led execution to behaviour-led engagement, enabling markets to prioritise high-impact activities and align investment to what drives real decision-making.
Created clarity on how global strategy should be applied locally, reducing fragmentation and improving consistency across markets.
Case FIVE
LAUNCH: From insight to behaviour change activation
A creative platform that reframes limitation, builds belief, and inspires audiences to see what's possible.
Creative launch platform
Read the behavioural approach
Objective
Enable successful entry into a new disease space by reshaping how cognitive limitation is understood — building belief, confidence, and recognition of patient potential.
Role of AI
AI-supported exploration of visual identity, tone, and narrative — accelerating the development of creative territories, imagery, and storytelling that bring the concept of human potential to life.
Impact
Reframed the condition from limitation to possibility, enabling patients and professionals to see beyond impairment and engage with a more optimistic, forward-looking narrative.
Built confidence in a new disease space, supporting recognition, emotional connection, and readiness to act.
Case SIX
Injecting patient PoV into strategic decision-making
Continuous feedback to refine involvement of patient perspective in planning across global and affiliate medical affairs teams.
Continuous patient feedback system
Read the behavioural approach
Objective
Enable global and affiliate medical affairs teams to systematically integrate patient perspectives into strategic planning, evidence generation, stakeholder engagement, and communication development.
Role of AI
AI-supported analysis accelerated synthesis of feedback, behavioural themes, and communication patterns — enabling faster identification of optimisation opportunities across engagement activities and markets.
Impact
Created a scalable framework for embedding patient-centric thinking into campaign preparation and medical affairs planning across markets.
Enabled teams to continuously refine engagement approaches using evolving patient feedback and real-world behavioural insight.
Capabilities
The work behind the outcome.
Frontera covers the connected work required to move from understanding a behaviour to changing it in market.
Research and intelligence
- Journey mapping
- Segmentation and profiling
- Behavioural evidence synthesis
- Insight mining
- KOL and influence mapping
- Message and asset testing
Strategy and planning
- Launch strategy
- Brand positioning
- Patient and HCP engagement strategy
- Omnichannel planning
- Performance frameworks
- Workshops and playbooks
Creative Digital Activation
- Campaign platforms
- Disease awareness
- Messaging systems
- Digital tools
- Congress experiences
- Personalised outreach
Start the conversation
Bring a live healthcare challenge. We will help frame the behavioural path forward.
Use the intro call to pressure-test a launch plan, patient support challenge, omnichannel question, or activation opportunity.
On the intro call
- 01Pressure-test a launch or activation challenge
- 02Identify behavioural friction in the journey
- 03Explore where AI can accelerate insight and targeting
- 04Discuss scalable outreach or GTM automation
- 05Define the next practical intervention